Testosterone Cypionate for Pain
Study Summary
This trial is testing whether testosterone replacement can help improve pain, sexual function, and quality of life for women with chronic back pain who also have low testosterone.
- Pain
- Opioid Use Disorder
- Low Testosterone
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2017 Phase 1 trial • 105 Patients • NCT01378299Awards & Highlights
Trial Design
Find a site
Who is running the clinical trial?
Media Library
Frequently Asked Questions
Is this clinical experiment currently accepting participants?
"Affirmative. The data hosted on clinicaltrials.gov indicates that the search for trial participants is ongoing, with this study having been posted on April 1st 2022 and most recently updated a month later."
For what medical purposes is Testosterone Cypionate regularly prescribed?
"Testosterone Cypionate is usually prescribed to treat hypogonadotropic hypogonadism, but it's also proven effective in cases of orchidectomy, orchitis and post-menopausal women between 1 - 5 years."
Has the United States Food and Drug Administration sanctioned Testosterone Cypionate?
"Our team at Power assigned Testosterone Cypionate a safety score of 2, as Phase 2 trials have demonstrated that it is safe but efficacy has yet to be proven."
How many participants have been recruited for this medical research?
"Affirmative, clinicaltrials.gov reveals that this medical study is actively recruiting participants. It was first announced on April 1st 2022 and the requirements were last amended on April 26th 2022. The research requires 40 patients to be recruited from one site."
Have there been prior investigations into Testosterone Cypionate?
"Currently, 29 separate clinical trials are underway assessing the efficacy of Testosterone Cypionate. 5 of these studies have reached Phase 3 status and 124 locations across the United States offer their services for this medication's research. The majority of sites researching testosterone cypionate reside in Houston, Texas."